114 patents currently held
37 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2026. from the record
Of the 37 now held by other companies, 11 name Board of Trustees of the Leland Stanford Junior University as their current owner, and 26 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
12
Ending by 2030
Dec 2026
Next term end
98
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Sep 2035 · Medium confidence
Also notable
Ends Jul 2029 · High confidence
Also notable
Ends Mar 2031 · High confidence
Also notable
Ends Oct 2033 · High confidence
Also notable
Ends Nov 2036 · High confidence
Also notable
Ends Jan 2036 · High confidence
Also notable
Ends Mar 2033 · High confidence
Also notable
Ends Jan 2033 · High confidence
Mutant Pores
US 11,034,734
The most cited patent in this portfolio, cited by 48 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2035. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Enhancing the T-Cells Stimulatory Capacity of Human Antigen Presenting Cells and Their Use in Vaccination
US 8,476,419
Cited by 30 later US patents, top 25% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Anti-Macrophage Mannose Receptor Single Variable Domains for Targeting and in Vivo Imaging of Tumor-Associated Macrophages
US 9,556,273
Cited by 21 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Vectors for Liver-Directed Gene Therapy of Hemophilia and Methods and Use Thereof
US 10,398,787
Cited by 22 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2033.
Optimized Liver-Specific Expression Systems for FVIII and FIX
US 11,007,280
Cited by 6 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2036.
Muscle-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof
US 10,731,177
A family of 5 related applications built on the 2020 grant. Protection runs to 2036.
Tools and Methods for Expression of Membrane Proteins
US 9,890,217
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2033.
Endotracheal Tube for Mechanical Ventilation
US 9,775,960
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2033.
Formerly held, still cited
Notable
Ends Jun 2033 · High confidence
Cited by 46 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2033.
now held by The Regents of the University of Michigan
Also notable
Ends Nov 2038 · High confidence
Cited by 32 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2038.
now held by Oxford Nanopore Technologies PLC
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Radio-Labelled Antibody Fragments for Use in the Prognosis, Diagnosis of Cancer as Well as for the Prediction of Cancer Therapy Response (US 11,660,356) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 2 fees due Dec 27, 2026
- 1 fee due Jan 2, 2027The maintenance fee for Means and Methods for Mediating Protein Interference (US 10,336,791) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 2 fees due Feb 11 to 22, 2027 · next Feb 11
- 2 fees due Mar 3, 2027
- 1 fee due Apr 13, 2027The maintenance fee for Reconstruction with Partially Known Attenuation Information In Time of Flight Positron Emission Tomography (US 9,155,514) comes due Apr 13, 2027. Unpaid by Oct 13, 2027, it lapses early.
- 3 fees due Jun 19 to 30, 2027 · next Jun 19
- 5 fees due Jul 2 to 16, 2027 · next Jul 2
- 3 fees due Sep 5 to 19, 2027 · next Sep 5
- 1 fee due Oct 2, 2027The maintenance fee for Fast and Robust Fourier Domain-Based Cell Differentiation (US 11,946,849) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
- 2 fees due Nov 5 to 7, 2027 · next Nov 5
Recent changes
- 5 of the patents on this record were granted since Aug 22, 2026
What they patent
The largest of its 98 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,095,556 | Method for Inducing Protein Aggregation Using a Polypeptide with an Aggregation Region held by Vib VZW and Vrije Universiteit Brussel In force · Medium confidence | In force | Medium confidence | |
| US 7,564,899 | Multistage Tuning-Tolerant Equalizer Filter In force · High confidence | In force | High confidence | |
| US 7,894,515 | Low Voltage Multistage Adaptive Equalizer held by Vrije Universiteit Brussel and Eqcologic N.V. In force · High confidence | In force | High confidence | |
| US 8,017,509 | Growth of Monocrystalline Gen on a Substrate In force · High confidence | In force | High confidence | |
| US 8,294,520 | Switchable Multiband Lna Design held by IMEC and Vrije Universiteit Brussel In force · High confidence | In force | High confidence | |
| US 9,408,909 | Enhancing the T-Cell Stimulatory Capacity of Human Antigen Presenting Cells in Vitro and in Vivo and Its Use in Vaccination In force · Medium confidence | In force | Medium confidence | |
| US 11,684,671 | Enhancing the T-Cell Stimulatory Capacity of Human Antigen Presenting Cells in Vitro and in Vivo and Its Use in Vaccination In force · Medium confidence | In force | Medium confidence | |
| US 8,199,043 | Comparator Based Asynchronous Binary Search A/D Conveter held by IMEC and Vrije Universiteit Brussel In force · High confidence | In force | High confidence | |
| US 8,956,453 | Method for Producing a Crystalline Germanium Layer on a Substrate held by IMEC and Vrije Universiteit Brussel In force · High confidence | In force | High confidence | |
| US 8,476,419 | Enhancing the T-Cells Stimulatory Capacity of Human Antigen Presenting Cells and Their Use in Vaccination In force · High confidence | In force | High confidence |
Also on record, not counted in the 114: 37 patents in force now held by others · 42 patents ended · 80 applications pending · 102 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.